Evidence map›Paper›PMID 42694905›Full record

ArticleAlpha psychiatry2026

Glutamatergic Modulators in Schizophrenia: Are We Ready to Move Beyond the Narrow Focus on Dopamine? A Potential Paradigm Shift in Psychopharmacology.

Renato de Filippis, Daniel Guinart, Christoph U Correll, Gaspare Liparota, Taishiro Kishimoto, Pasquale De Fazio

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Alpha psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Renato de FilippisPsychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.ORCID https://orcid.org/0000-0001-6928-1224
Daniel GuinartInstitut de Salut Mental, Hospital del Mar, 08003 Barcelona, Spain.ORCID https://orcid.org/0000-0001-5078-6716
Christoph U CorrellDepartment of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY 11549, USA.ORCID https://orcid.org/0000-0002-7254-5646
Gaspare LiparotaPsychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.
Taishiro KishimotoCenter for the Promotion of Interdisciplinary Research in Medicine and Life Science (PIRMS), Keio University School of Medicine, 160-8582 Tokyo, Japan.
Pasquale De FazioPsychiatry Unit, Department of Health Sciences, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy.ORCID https://orcid.org/0000-0001-5375-3565

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antipsychotic agentscognition disordersglutamatergic neuronsreceptors, metabotropic glutamatereceptors, N-methyl-D-aspartate

Identifiers

PMID42694905
PMCPMC13540019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.